Yousif Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.69M | Sell |
67,040
-1,021
| -2% | -$56.1K | 0.04% | 430 |
|
|
2025
Q1 | $4.81M | Sell |
68,061
-1,708
| -2% | -$121K | 0.06% | 325 |
|
|
2024
Q4 | $4.59M | Sell |
69,769
-3,068
| -4% | -$202K | 0.05% | 346 |
|
|
2024
Q3 | $5.12M | Sell |
72,837
-9,308
| -11% | -$654K | 0.06% | 327 |
|
|
2024
Q2 | $6.76M | Buy |
82,145
+79,731
| +3,303% | +$6.56M | 0.08% | 235 |
|
|
2024
Q1 | $211K | Buy |
2,414
+198
| +9% | +$17.3K | ﹤0.01% | 1854 |
|
|
2023
Q4 | $214K | Buy |
+2,216
| New | +$214K | ﹤0.01% | 1864 |
|
|
2023
Q2 | – | Sell |
-2,163
| Closed | -$210K | – | 1969 |
|
|
2023
Q1 | $210K | Buy |
2,163
+85
| +4% | +$8.27K | ﹤0.01% | 1825 |
|
|
2022
Q4 | $215K | Buy |
+2,078
| New | +$215K | ﹤0.01% | 1811 |
|
|
2022
Q2 | – | Sell |
-2,641
| Closed | -$204K | – | 1981 |
|
|
2022
Q1 | $204K | Buy |
2,641
+55
| +2% | +$4.25K | ﹤0.01% | 1912 |
|
|
2021
Q4 | $228K | Buy |
+2,586
| New | +$228K | ﹤0.01% | 1893 |
|